| Absorption | 
      | Blood-Brain Barrier | BBB- | 0.9770 | 
      | Human Intestinal Absorption | HIA+ | 0.8981 | 
      | Caco-2 Permeability | Caco2- | 0.7773 | 
      | P-glycoprotein Substrate | Substrate | 0.6649 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8456 | 
                                                     | Non-inhibitor | 0.9262 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.9457 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.7385 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.8026 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8846 | 
      | CYP450 3A4 Substrate | Substrate | 0.6507 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.8887 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.8902 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9159 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.8725 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.7113 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7298 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9947 | 
                                                                    | Non-inhibitor | 0.7318 | 
      | AMES Toxicity | Non AMES toxic | 0.8123 | 
      | Carcinogens | Non-carcinogens | 0.8334 | 
      | Fish Toxicity | High FHMT | 0.9939 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.9655 | 
      | Honey Bee Toxicity | Low HBT | 0.6869 | 
      | Biodegradation | Not ready biodegradable | 1.0000 | 
      | Acute Oral Toxicity | III | 0.7956 | 
      | Carcinogenicity (Three-class) | Non-required | 0.6614 |